Skip to main content

Advertisement

Log in

Effects of allitridin on acute and chronic mouse cytomegalovirus infection

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

This study investigated the effects of allitridin on acute and chronic mouse cytomegalovirus (MCMV) infections in vivo. The results demonstrated that allitridin reduced the titers of MCMV in salivary glands, and reductions in viral loads were confirmed by determining viral DNA and RNA levels in susceptible organs during the acute infection phase. Although allitridin did not eliminate MCMV, treatment reduced viral levels and facilitated healing of pathologic lesions in organs, particularly during the chronic infection phase. The results presented in this report suggest that allitridin could act as an effective agent against MCMV infections in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202–213

    Article  PubMed  Google Scholar 

  2. Sequar G, Britt WJ, Lakeman FD, Lockridge KM, Tarara RP, Canfield DR, Zhou SS, Gardner MB, Barry PA (2002) Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: pathogenesis. J Virol 76:7661–7671

    Article  PubMed  CAS  Google Scholar 

  3. Hummel M, Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25(Suppl 2):S123–S136

    Article  PubMed  Google Scholar 

  4. Slobedman B, Cao JZ, Avdic S, Webster B, McAllery S, Cheung AKL, Tan JCG, Abendroth A (2010) Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol 5:883–900

    Article  PubMed  CAS  Google Scholar 

  5. Reeves M, Sinclair J (2008) Aspects of human cytomegalovirus latency and reactivation. Human Cytomegalovirus 325:297–313

    Article  CAS  Google Scholar 

  6. Marschall M, Stamminger T (2009) Molecular targets for antiviral therapy of cytomegalovirus infections. Future Microbiol 4:731–742

    Article  PubMed  CAS  Google Scholar 

  7. Biron KK (2006) Antiviral drugs for cytomegalovirus diseases. Antiviral Res 71:154–163

    Article  PubMed  CAS  Google Scholar 

  8. Andrei G, De Clercq E, Snoeck R (2009) Drug targets in cytomegalovirus infection. Infect Disord Drug Targets 9:201–222

    PubMed  CAS  Google Scholar 

  9. Powolny AA, Singh SV (2008) Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett 269:305–314

    Article  PubMed  CAS  Google Scholar 

  10. Liu ZF, Fang F, Dong YS, Li G, Zhen H (2004) Experimental study on the prevention and treatment of murine cytomegalovirus hepatitis by using allitridin. Antiviral Res 61:125–128

    Article  PubMed  CAS  Google Scholar 

  11. Yi X, Feng F, Xiang Z, Ge L (2005) The effects of allitridin on the expression of transcription factors T-bet and GATA-3 in mice infected by murine cytomegalovirus. J Med Food 8:332–336

    Article  PubMed  CAS  Google Scholar 

  12. Zhen H, Fang F, Ye DY, Shu SN, Zhou YF, Dong YS, Nie XC, Li G (2006) Experimental study on the action of allitridin against human cytomegalovirus in vitro: inhibitory effects on immediate-early genes. Antiviral Res 72:68–74

    Article  PubMed  CAS  Google Scholar 

  13. Xu SY, Bian RN, Chen X (1991) Methodology of pharmacological experiments, 2nd edn. People’s Medical Publishing House, Beijing, pp 178–179

    Google Scholar 

  14. Campbell AE, Cavanaugh VJ, Slater JS (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197:205–213

    Article  PubMed  Google Scholar 

  15. Vliegen I, Herngreen S, Grauls G, Bruggeman C, Stassen F (2003) Improved detection and quantification of mouse cytomegalovirus by real-time PCR. Virus Res 98:17–25

    Article  PubMed  CAS  Google Scholar 

  16. Papadimitriou JM, Shellam GR, Allan JE (1982) The effect of the beige mutation on infection with murine cytomegalovirus: histopathologic studies. Am J Pathol 108:299–309

    PubMed  CAS  Google Scholar 

  17. Selgrade MK, Collier AM, Saxton L, Daniels MJ, Graham JA (1984) Comparison of the pathogenesis of murine cytomegalovirus in lung and liver following intraperitoneal or intratracheal infection. J Gen Virol 65:515–523

    Article  PubMed  Google Scholar 

  18. Lenzo JC, Fairweather D, Cull V, Shellam GR, James Lawson CM (2002) Characterization of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. J Mol Cell Cardiol 34:629–640

    Article  PubMed  CAS  Google Scholar 

  19. Cui W, Dong Y, Fang F (2002) Experimental study of mouse cytomegalovirus infected mice. J Huazhong Univ Sci Technolog Med Sci 22:260–226

    Google Scholar 

Download references

Acknowledgments

This work was sponsored by a grant (no. 30572345) from the National Natural Science Foundation of China, awarded to Feng Fang.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Feng Fang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Xl., Wang, H., Li, Yn. et al. Effects of allitridin on acute and chronic mouse cytomegalovirus infection. Arch Virol 156, 1841–1846 (2011). https://doi.org/10.1007/s00705-011-1025-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-011-1025-9

Keywords

Navigation